Notice of Effectiveness (effect)
24 Octubre 2022 - 5:05AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | October 21,
2022 |
---|
Form: | S-3 |
---|
CIK: | 0000882361 |
---|
Company Name: | Aptose Biosciences Inc. |
---|
File Number: | 333-267801 |
---|
Aptose Biosciences (NASDAQ:APTO)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Aptose Biosciences (NASDAQ:APTO)
Gráfica de Acción Histórica
De May 2023 a May 2024